UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange

Act of 1934 Date of Report (Date of earliest event reported):

 

  November 9, 2015

 

KANGE CORP.

(Exact name of registrant as specified in its charter)

 

Nevada

 

333-194055

 

33-1230169

(State of incorporation)

 

(Commission File Number)

 

(IRS Employer No.)

 

2770 S. Maryland Pkwy.
#302 Las Vegas, Nevada
89109

(Address of principal executive offices and Zip Code)

 

(702) 731-3535

(Registrant's telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

 

 

 

 

Item 3.02 Unregistered Sales of Equity Securities

 

On November 9, 2015, Kange Corp. (the "Company") issued 50,000 shares of the Company's common stock to Victor Stepanov, the Chief Executive Officer and Director of the Company, pursuant to the terms of his employment agreement with the Company.

 

Also on November 9, 2015, the Company issued 5,000,000 shares of common stock to AMJ Global, LLC ("AMJ"), a limited liability company beneficially owned by Dr. Arthur Malone, Jr., simultaneous with the appointment of Dr. Malone as officer and director as described in Item 5.02 and incorporated by reference herein, and in consideration of AMJ's assignment of contract rights described in Item 8.01 and incorporated by reference herein.

 

The securities described herein were issued pursuant to exemptions from registration requirements relying on Section 4(a)(2) of the Securities Act of 1933 and upon Rule 506 of Regulation D of the Securities Act of 1933, as there was no general solicitation, and the transactions did not involve a public offering.

 

Item 5.01 Changes in Control of Registrant

 

The issuance of 5,000,000 shares to AMJ described in Item 3.02 and incorporated by reference herein constituted a change of control to AMJ as AMJ now owns 67.3% of the voting securities of the Company after issuance of the shares.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On November 9, 2015, Victor Stepanov resigned as President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer and Director, and appointed Dr. Arthur Malone, Jr. as President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer and Director.

 

Dr. Arthur "Art" Malone, Jr. is 49 years old. He resides in Calabasas, California. From 2010-2015, Dr. Malone has been an entrepreneur, whether it be from investing in public and private companies to creating business opportunities for those not as fortunate, to advising public or private companies on corporate structure. Dr. Malone was formerly the Chairman and CEO of Songstagram, a mobile app company, that he resigned from, and which sold its interests in licensing agreements to publicly traded company, bBooth, Inc. Dr. Malone through his company, AMJ Global, has also created a clothing line as well as an entertainment company, and Dr. Malone taught over 5 years at Channel Islands Bible College. Dr. Malone attended the University of Washington where he studied Criminal Law and Sociology. Dr. Malone also attended Kings Seminary as well as Channel Islands Bible College. Dr. Malone holds a Bachelor's Degree, as well as two Masters Degrees and a Ph.D. The Company b elieves that Dr. Malone's extensive experience in the technology sector and with small public companies qualifies him to serve as a director of the Company.

 

The terms of Dr. Malone's employment have not yet been determined.

 

Item 8.01 Other Events

 

On November 9, 2015, AMJ Global, LLC, assigned its rights pursuant to its agreements with Blabeey Inc. to the Company. The foregoing description of the assignment is qualified in its entirety by the text of such assignment, filed as Exhibit 99.1 hereto, and incorporated by reference in this report.

 

Item 9.01 Financial Statements and Exhibits

 

The exhibits listed in the following Exhibit Index are filed as part of this report:

 

99.1

Assignment of Rights Agreement

 

 
2
 


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Kange Corp.

 

       

Date: November 12, 2015

By: /s/ Dr. Arthur Malone, Jr.

 

 

 

Dr. Arthur Malone, Jr.

 

 

 

Chief Executive Officer

 

 

 

3


EXHIBIT 99.1

 

ASSIGNMENT OF RIGHTS AGREEMENT

 

Hereby, AMJ Global LLC. (herein called "AMJ"), located at 26731 Mont Calabasas Drive, Calabasas, California 91302, irrevocably assigns, transfers and conveys in its entirety to Kange Corp., located at 2770 S. Maryland Pkwy. # 302, Las Vegas, Nevada, 89109, a ll of its rights and obligations that are stipulated and set forth in every and all agreements between AMJ and Blabeey Inc., including but not limited to the agreement between the same dated to 10-26-2015.

 

 

By: 

/s/ Victor Stepanov

 

By:

/s/ Dr. Art Malone

 

 

Victor Stepanov

 

 

Dr. Art Malone

 

 

for Kange Corp.

 

 

for AMJ Global, LLC.